Robert J. Terifay

2013

In 2013, Robert J. Terifay earned a total compensation of $7.7M as Executive Vice President, Commercial at Regeneron Pharmaceuticals, a 3% increase compared to previous year.

Compensation breakdown

Bonus$364,500
Option Awards$6,847,486
Salary$450,000
Other$17,145
Total$7,679,131

Terifay received $6.8M in option awards, accounting for 89% of the total pay in 2013.

Terifay also received $364.5K in bonus, $450K in salary and $17.1K in other compensation.

Rankings

In 2013, Robert J. Terifay's compensation ranked 675th out of 12,286 executives tracked by ExecPay. In other words, Terifay earned more than 94.5% of executives.

ClassificationRankingPercentile
All
675
out of 12,286
95th
Division
Manufacturing
223
out of 4,612
95th
Major group
Chemicals And Allied Products
56
out of 1,462
96th
Industry group
Drugs
35
out of 1,156
97th
Industry
Pharmaceutical Preparations
32
out of 890
96th
Source: SEC filing on April 26, 2016.

Terifay's colleagues

We found five more compensation records of executives who worked with Robert J. Terifay at Regeneron Pharmaceuticals in 2013.

2013

Leonard Schleifer

Regeneron Pharmaceuticals

Chief Executive Officer

2013

George Yancopoulos

Regeneron Pharmaceuticals

Chief Scientific Officer

2013

Neil Stahl

Regeneron Pharmaceuticals

Executive Vice President, Research & Development

2013

Robert Landry

Regeneron Pharmaceuticals

Chief Financial Officer

2013

Murray Goldberg

Regeneron Pharmaceuticals

Chief Financial Officer

In-depth

You may also like